Diabetes
Browse content by category
Featured insights and resources
We didn't find any resources that match your selection.
Please adjust your filter(s) and try again.
ADA Standards of Medical Care in Diabetes – 2024
Algorithms and updates from the 2024 guidelines.
Changes over time in the cardiovascular risk profile of type 2 diabetes from 2007 to 2020: A community-based study
Manuscript quantifying changes over time in CV risk factor control and uptake of GLP1RA and SGLT2 inhibitors from 2007 to 2020 in a real-world community-based cohort of T2D patients.
Stroke outcomes in T2D (Poster)
The poster discusses stroke outcomes in patients with T2D
Find more information
Find product information
Explore our portfolio of products for treating diabetes, including prescribing information, safety data sheets, and storage and stability information.
Continuing education
Explore accredited diabetes education opportunities supported by Novo Nordisk and provided by third-party organizations.
The purpose of this site is to provide relevant medical and scientific information about Novo Nordisk products and areas of therapeutic interest. Information about investigational products or investigational uses of approved products neither implies FDA approval for these products or uses, nor establishes the safety or efficacy of these products or uses. There is no guarantee that any investigational product or investigational use will receive FDA approval or become commercially available in the United States. Novo Nordisk does not recommend or suggest use of its products in any manner inconsistent with FDA-approved labeling.
This site is intended for United States healthcare professionals only. The information on this site—including all product information—pertains to residents of the United States only. Any products referenced on this site may have different labelling in different countries.
